www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Top News

Vaccines face higher levels of scrutiny, quality control

By Wang Xiaodong | China Daily | Updated: 2019-03-12 09:00
Share
Share - WeChat
Zhang Mao, head of the State Administration of Market Regulation, speaks with reporters after a news conference on market supervision during the ongoing session of the 13th National People's Congress in Beijing on Monday. [Photo by Feng Yongbin/China Daily]

Shortcomings in anti-rabies product last year prompted oversight changes

Drug regulators and vaccine producers will face intensified scrutiny to ensure product safety and quality, a top drug supervision official said on Monday.

Vaccines are a major public health issue because they involve matters of life and death as well as national security, and efforts are now being made to establish an effective supervisory mechanism over vaccines, said Jiao Hong, head of the China Medical Products Administration.

To ensure effective supervision over the sector, the administration will focus on urging vaccine producers and local drug authorities to carry out their respective duties, Jiao said at a news conference in Beijing during the annual sessions of China's top legislative and advisory bodies.

Vaccine producers must take measures to ensure the quality of their products, including establishing sound quality control systems and product tracing systems, and also implement product risk report regulations, she said.

The administration will further clarify supervisory responsibilities on the part of local drug authorities, and urge provincial-level drug authorities to intensify site inspections over vaccine producers, she said.

The administration will increase patrols and random inspections over vaccine producers across the country, and severely punish violators, Jiao said.

Meanwhile, it will improve training of drug inspection officers to improve their efficiency, she said.

The safety and quality of drugs have been a major public concern over the past few years in China, with sporadic reports of alarming incidents such as the use of expired vaccines.

Changchun Changsheng Bio-tech Co, a major producer of a rabies vaccine in Jilin province, was found by China's top drug regulator last year to have committed various violations such as using expired materials and faking production over a four-year period.

Although no deaths or injuries linked to the case have been reported, the incident shocked the nation, prompting top officials to vow intensified supervision over the sector.

A new law, the Vaccine Administration Law, which imposes much higher penalties on violators, was drafted and submitted to the top legislature for review at the end of last year.

A Chinese medical worker prepares to vaccinate a young kid at a hospital in Shanghai, China, March 20, 2016. [Photo/IC]

Jiao said the new law will impose stricter supervision over vaccines, covering the whole manufacturing chain including research and development, production, circulation and use.

"We are working with related departments to research and formulate additional legal regulations and rules to prepare for its implementation," Jiao said.

Gao Fu, head of the Chinese Center for Disease Control and Prevention, said incidents such as the Changchun Changsheng case are just individual cases and do not represent the entire sector.

"We should not compromise our faith in the power of vaccines in disease prevention and control, nor in the quality and safety of vaccines produced in China," he said.

Fang Laiying, a member of the 13th National Committee of the Chinese People's Political Consultative Conference, China's top political advisory body, suggested during the body's ongoing annual session that a product-tracing system be established to ensure the safety and quality of vaccines.

"Every box of vaccines should have a code that stores product information, including its date of manufacture, circulation and use, so the batch can be quickly recalled if anyone reports quality problems, and users of such vaccines can be precisely identified," said Fang, who is also vice-president of the Chinese Hospital Association.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 中文字幕一二三区乱码老 | 欧美精品一级毛片 | 国产成人18黄网站免费网站 | 老师张开腿让我爽了一夜视频 | 欧洲一级大片 | 亚洲天堂男人在线 | 日韩中文在线 | 久久精品在现线观看免费15 | 欧美日韩国产综合一区二区三区 | 亚洲综合性 | 性色综合 | 国产色司机在线视频免费观看 | 久久精品亚洲一级毛片 | 一级欧美一级日韩片 | 一个人看的日本免费视频 | 国产毛片网站 | 国产亚洲精品久久久久久久久激情 | 欧美成人亚洲 | 免费视频日本 | 国产亚洲小视频 | 第四色成人网 | 欧美日韩加勒比一区二区三区 | 91精品手机国产在线能 | 久久精品国产精品亚洲艾 | 欧美精品成人久久网站 | 亚洲精品www | 国产精品久久毛片蜜月 | 国产福利最新手机在线观看 | 蜜桃日本一道无卡不码高清 | 我要看欧美精品一级毛片 | 久久国产亚洲欧美日韩精品 | 亚洲视频免费一区 | 亚洲 欧美 成人日韩 | 国产成人午夜精品影院游乐网 | 日韩专区亚洲国产精品 | 毛片在线视频观看 | 天堂va欧美ⅴa亚洲va一国产 | 韩国毛片基地 | 亚洲综合色自拍一区 | 九九黄色影院 | 看一级毛片一区二区三区免费 |